Analysts Viewpoint Negative sentiment towards PTGX reflected by a jump of 10.59% in short interest Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Protagonist Therapeutics
Analysts Viewpoint Analyzing Protagonist Therapeutics Inc (PTGX) After Recent Trading Activity Protagonist Therapeutics Inc’s recently made public that its Chief Medical Officer MOLINA ARTURO MD unloaded Company’s shares for reported $0.57
Insiders Updates Sharp increase in PTGX’s short interest leads to surge in days-to-cover ratio The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or